Predicting genome-wide DNA methylation using methylation marks, genomic position, and DNA regulatory elements

Genome Biology

Volumn 16, Issue 1, 2015, Pages

  Zhang, Weiwei ^a   Spector, Tim D ^b   Deloukas, Panos ^c,d   Bell, Jordana T ^b   Engelhardt, Barbara E ^e  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^e Princeton University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; HISTONE H3; HISTONE H3K4ME3; MAX PROTEIN; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG; HYDROGEN SULFITE; SULFITE;

ADULT; AGED; ARTICLE; BINDING SITE; CONTROLLED STUDY; CPG ISLAND; DECISION TREE; DNA METHYLATION; ELF1 GENE; ENZYME LOCALIZATION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC DISTANCE; HISTONE MODIFICATION; HUMAN; MALE; MAZ GENE; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; MXI1 GENE; PREDICTIVE VALUE; RANDOM FOREST; REGULATORY DNA SEQUENCE; RUNX3 GENE; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; ALGORITHM; DNA SEQUENCE; GENETICS; GENOMICS; HUMAN GENOME; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; REGULATORY SEQUENCE;

ADULT; AGED; ALGORITHMS; CPG ISLANDS; DNA METHYLATION; FEMALE; GENOME, HUMAN; GENOMICS; HUMANS; MALE; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE ANALYSIS, DNA; SULFITES;

EID: 84939205466     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/s13059-015-0581-9     Document Type: Article

References (107)

1. Barrero MJ, Boué S, Izpisúa Belmonte JC. Epigenetic mechanisms that regulate cell identity. Cell Stem Cell. 2010; 7:565-70.
2. Scarano MI, Strazzullo M, Matarazzo MR, D'Esposito M. DNA methylation 40 years later: Its role in human health and disease. J Cell Physiol. 2005; 204:21-35.
3. Cedar H, Bergman Y. Programming of DNA methylation patterns. Annu Rev Biochem. 2012; 81:97-117.
4. Kiefer JC. Epigenetics in development. Dev Dyn. 2007; 236:1144-56.
5. Tost J. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker. Mol Biotechnol. 2010; 44:71-81.
6. Cedar H. DNA methylation and gene activity. Cell. 1988; 1964:93-124.
7. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003; 33:245-54.
8. Wolffe AP, Matzke MA. Epigenetics: regulation through repression. Science. 1999; 286:481-6.
9. Rivenbark AG, Stolzenburg S, Beltran AS, Yuan X, Rots MG, Strahl BD, et al. Epigenetic reprogramming of cancer cells via targeted DNA methylation. Epigenetics Official J DNA Methylation Soc.2012;7. http://www.ncbi.nlm.nih.gov/pubmed/22419067 .
10. Das PM, Singal R. DNA methylation and cancer. J Clin Oncol. 2004; 22:4632-42.
11. Lienert F, Wirbelauer C, Som I, Dean A, Mohn F, Schübeler D. Identification of genetic elements that autonomously determine DNA methylation states. Nat Genet. 2011; 43:1091-7.
12. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet. 2011; 13:484-92.
13. Law JA, Jacobsen SE. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat Rev Genet. 2010; 11:204-20.
14. Shen L, Kondo Y, Guo Y, Zhang J, Zhang L, Ahmed S, et al. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet. 2007; 3:2023-36.
15. Larsen F, Gundersen G, Lopez R, Prydz H. CpG islands as gene markers in the human genome. Genomics. 1992; 13:1095-107.
16. Brandeis M, Frank D, Keshet I, Siegfried Z, Mendelsohn M, Nemes A, et al. Sp1 elements protect a CpG island from de novo methylation. Nature. 1994; 371:435-8.
17. Macleod D, Charlton J, Mullins J, Bird AP. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 1994; 8:2282-92.
18. Dickson J, Gowher H, Strogantsev R, Gaszner M, Hair A, Felsenfeld G, et al. VEZF1 elements mediate protection from DNA methylation. PLoS Genet. 2010; 6:e1000804.
19. Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Gayther SA, Apostolidou S, et al. An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One. 2009; 4:e8274.
20. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011; 25:1010-22.
21. Choy MK, Movassagh M, Goh HG, Bennett MR, Down T a, Foo RSY. Genome-wide conserved consensus transcription factor binding motifs are hyper-methylated. BMC Genomics. 2010; 11:519.
22. Gebhard C, Benner C, Ehrich M, Schwarzfischer L, Schilling E, Klug M, et al. General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells. Cancer Res. 2010; 70:1398-407.
23. Stirzaker C, Song JZ, Davidson B, Clark SJ. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res. 2004; 64(11):3871-7.
24. Valenzuela L, Kamakaka RT. Chromatin insulators. Annu Rev Genet. 2006; 40:107-38.
25. Weber M, Hellmann I, Stadler MB, Ramos L, Pääbo S, Rebhan M, et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet. 2007; 39:457-66.
26. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature. 2008; 454:766-70.
27. Hawkins RD, Hon GC, Lee LK, Ngo Q, Lister R, Pelizzola M, et al. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell. 2010; 6:479-91.
28. Das R, Dimitrova N, Xuan Z, Rollins Ra, Haghighi F, Edwards JR, et al. Computational prediction of methylation status in human genomic sequences. Proc Natl Acad Sci U S A. 2006; 103:10713-16.
29. Laird PW. Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet. 2010; 11:191-203.
30. Laurent L, Wong E, Li G, Huynh T, Tsirigos A, Ong CT, et al. Dynamic changes in the human methylome during differentiation. Genome Res. 2010; 20:320-31.
31. Hon G, Antosiewicz-bourget J, Malley RO, Castanon R. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature. 2011; 471(7336):68-73.
32. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009; 462:315-22.
33. Sandoval J, Heyn HA, Moran S, Serra-Musach J, Pujana MA, Bibikova M, et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics Official J DNA Methylation Soc. 2011; 6:692-702.
34. Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, et al. High density DNA methylation array with single CpG site resolution. Genomics. 2011; 98:288-95.
35. Bell JT, Pai AA, Pickrell JK, Gaffney DJ, Pique-Regi R, Degner JF, et al. DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines. Genome Biol. 2011; 12:R10.
36. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet. 2006; 38:1378-85.
37. Fernandez AF, Assenov Y, Martin-Subero JI, Balint B, Siebert R, Taniguchi H, et al. A DNA methylation fingerprint of 1628 human samples. Genome Res. 2011; 22:407-19.
38. Ma B, Wilker EH, Willis-Owen SAG, Byun HM, Wong KCC, Motta V, et al. Predicting DNA methylation level across human tissues. Nucleic Acids Res. 2014; 42:3515-28.
39. Bhasin M, Zhang H, Reinherz EL, Reche PA. Prediction of methylated CpGs in DNA sequences using a support vector machine. FEBS Lett. 2005; 579:4302-8.
40. Bock C, Paulsen M, Tierling S, Mikeska T, Lengauer T, Walter J. CpG island methylation in human lymphocytes is highly correlated with DNA sequence, repeats, and predicted DNA structure. PLoS Genet. 2006; 2:e26.
41. Fang F, Fan S, Zhang X, Zhang MQ. Predicting methylation status of CpG islands in the human brain. Bioinformatics (Oxford, England). 2006; 22:2204-9.
42. Kim S, Li M, Paik H, Nephew K, Shi H, Kramer R, et al. Predicting DNA methylation susceptibility using CpG flanking sequences. Pac Symp Biocomput. 2008; 326:315-26.
43. Fan S, Zhang MQ, Zhang X. Histone methylation marks play important roles in predicting the methylation status of CpG islands. Biochem Biophys Res Commun. 2008; 374:559-64.
44. Lu L. Predicting DNA methylation status using word composition. J Biomed Sci Eng. 2010; 03:672-76.
45. Zheng H, Wu H, Li J, Jiang SW. CpGIMethPred: computational model for predicting methylation status of CpG islands in human genome. BMC Med Genomics. 2013; 6:S13.
46. Previti C, Harari O, Zwir I, del Val C. Profile analysis and prediction of tissue-specific CpG island methylation classes. BMC Bioinformatics. 2009; 10:116.
47. Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature. 2010; 466:253-7.
48. Zhou X, Li Z, Dai Z, Zou X. Prediction of methylation CpGs and their methylation degrees in human DNA sequences. Comput Biol Med. 2012; 42(4):408-13.
49. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 2005; 15:1034-50.
50. Heyn H, Carmona FJ, Gomez A, Ferreira HJ, Bell JT, Sayols S, et al. DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker. Carcinogenesis. 2013; 34:102-8.
51. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler a M, et al. The human genome browser at UCSC. Genome Res. 2002; 12:996-1006.
52. Durbin RM, Altshuler DL, Abecasis GR, Bentley DR, Chakravarti A, Clark AG, et al. A map of human genome variation from population-scale sequencing. Nature. 2010; 467:1061-73.
53. ' ends of regions of transcription. Proc Natl Acad Sci U S A. 1981; 78:143-6.
54. Bernat JA, Crawford GE, Ogurtsov AY, Collins FS, Ginsburg D, Kondrashov AS. Distant conserved sequences flanking endothelial-specific promoters contain tissue-specific DNase-hypersensitive sites and over-represented motifs. Hum Mol Genet. 2006; 15:2098-105.
55. International HapMap Consortium. A haplotype map of the human genome. Nature. 2005; 437:1299-1320.
56. Good PJ, Guyer MS, Kamholz S, Liefer L, Wetterstrand K, Kampa D, et al. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science. 2004; 306:636-40.
57. Voight BF, Kudaravalli S, Wen X, Pritchard JK. A map of recent positive selection in the human genome. PLoS Biol. 2006; 4:e72.
58. Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, Batzoglou S. Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput Biol. 2010; 6:e1001025.
59. Ziller MJ, Gu H, Müller F, Donaghey J, Tsai LTY, Kohlbacher O, et al. Charting a dynamic DNA methylation landscape of the human genome. Nature. 2013,:1-5. http://www.nature.com/doifinder/10.1038/nature12433 .
60. Hodges E, Molaro A, Dos Santos CO, Thekkat P, Song Q, Uren PJ, et al. Directional DNA methylation changes and complex intermediate states accompany lineage specificity in the adult hematopoietic compartment. Mol Cell. 2011; 44:17-28.
61. He H, Garcia E. Learning from imbalanced data. IEEE Trans Knowl Data Eng. 2009; 21:1263-84.
62. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 2009; 41:178-86.
63. Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet. 2009; 41:1350-3.
64. Tsumagari K, Baribault C, Terragni J, Varley KE, Gertz J, Pradhan S, et al. Early de novo DNA methylation and prolonged demethylation in the muscle lineage. Epigenetics: Official J DNA Methylation Soc. 2013; 8:317-32.
65. Hogart A, Lichtenberg J, Ajay SS, Anderson S, Intramural NIH, Margulies EH, et al. Genome-wide DNA methylation profiles in hematopoietic stem and progenitor cells reveal overrepresentation of ETS transcription factor binding sites. Genome Res. 2012; 22:1407-18.
66. Chuang LSH, Ito Y. RUNX3 is multifunctional in carcinogenesis of multiple solid tumors. Oncogene. 2010; 29:2605-15.
67. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue KI, Chi XZ, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell. 2002; 109:113-24.
68. Kim WJ, Kim EJ, Jeong P, Quan C, Kim J, Li QL, et al. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res. 2005; 65:9347-54.
69. Lau QC, Raja E, Salto-Tellez M, Liu Q, Ito K, Inoue M, et al. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res. 2006; 66:6512-20.
70. Sato K, Tomizawa Y, Iijima H, Saito R, Ishizuka T, Nakajima T, et al. Epigenetic inactivation of the RUNX3 gene in lung cancer. Oncol Rep. 2006; 15:129-35.
71. Weisenberger D, D Siegmund K, Campan M, Young J, Long T, Faasse M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet. 2006; 38:787-93.
72. Lázcoz P, Muñoz J, Nistal M, Pestaña A, Encío IJ, Castresana JS. Loss of heterozygosity and microsatellite instability on chromosome arm 10q in neuroblastoma. Cancer Genet Cytogenet. 2007; 174:1-8.
73. Song J, Ugai H, Kanazawa I, Sun K, Yokoyama KK. Independent repression of a GC-rich housekeeping gene by Sp1 and MAZ involves the same cis-elements. J Biol Chem. 2001; 276:19897-904.
74. Song J, Ugai H, Nakata-Tsutsui H, Kishikawa S, Suzuki E, Murata T, et al. Transcriptional regulation by zinc-finger proteins Sp1 and MAZ involves interactions with the same cis-elements. Int J Mol Med. 2003; 11:547-53.
75. Baron B. Breaking the silence: the interplay between transcription factors and DNA methylation. In: Methylation - from DNA, RNA and histones to diseases and treatment. Rejika, Croatia: InTech: 2012. p. 3-26.
76. Guccione E, Martinato F, Finocchiaro G, Luzi L, Tizzoni L, Dall' Olio V, et al. Myc-binding-site recognition in the human genome is determined by chromatin context. Nat Cell Biol. 2006; 8:764-70.
77. Toyota M, Suzuki H. Epigenetic drivers of genetic alterations. Adv Genet. 2010; 70:309-23.
78. Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Watkins DN, et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res. 2000; 60:2368-71.
79. Yang J, Ferreira T, Morris A P, Medland SE, Madden PAF, Heath AC, et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat Genet. 2012; 44:369-75.
80. Mangravite LM, Engelhardt BE, Medina MW, Smith JD, Brown CD, Chasman DI, et al. A statin-dependent QTL for GATM expression is associated with statin-induced myopathy. Nature. 2013; 502:377-80.
81. Lokk K, Modhukur V, Rajashekar B, Märtens K, Mägi R, Kolde R, et al. DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns. Genome Biol. 2014; 15:R54.
82. Jaffe AE, Irizarry RA. Accounting for cellular heterogeneity is critical in epigenome-wide association studies. Genome Biol. 2014; 15:R31.
83. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009; 5:e1000529.
84. Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet. 2012; 44:955-9.
85. Zhu Q, Ge D, Maia JM, Zhu M, Petrovski S, Dickson SP, et al. A genome-wide comparison of the functional properties of rare and common genetic variants in humans. Am J Hum Genet. 2011; 88:458-68.
86. McClellan J, King MC. Genetic heterogeneity in human disease. Cell. 2010; 141:210-7.
87. Zou J, Lippert C, Heckerman D, Aryee M, Listgarten J. Epigenome-wide association studies without the need for cell-type composition. Nat Methods. 2014; 11:4-8.
88. Gibbs JR, Van Der Brug M P, Hernandez DG, Traynor BJ, Nalls MA, Lai SL, et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet. 2010; 6:13.
89. Zhang D, Cheng L, Badner JA, Chen C, Chen Q, Luo W, et al. Genetic control of individual differences in gene-specific methylation in human brain. Am J Hum Genet. 2010; 86:411-19.
90. Degner JF, Pai Aa, Pique-Regi R, Veyrieras JB, Gaffney DJ, Pickrell JK, et al. DNase I sensitivity QTLs are a major determinant of human expression variation. Nature. 2012; 482:390-4.
91. Pai AA, Cain CE, Mizrahi-Man O, De Leon S, Lewellen N, Veyrieras JB, et al. The contribution of RNA decay quantitative trait loci to inter-individual variation in steady-state gene expression levels. PLoS Genet. 2012; 8:e1003000.
92. Gaffney DJ, Veyrieras JB, Degner JF, Pique-Regi R, Pai AA, Crawford GE, et al. Dissecting the regulatory architecture of gene expression QTLs. Genome Biol. 2012; 13:R7.
93. Moayyeri A, Hammond CJ, Valdes AM, Spector TD. Cohort profile: TwinsUK and healthy ageing twin study. Int J Epidemiol. 2012. http://www.ncbi.nlm.nih.gov/pubmed/22253318 .
94. Rechache NS, Wang Y, Stevenson HS, Killian JK, Edelman DC, Merino M, et al. DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors. J Clin Endocrinol Metab. 2012; 97:E1004-13.
95. R project. http://www.r-project.org/.
96. Gabriel KR, Odoroff CL. Biplots in biomedical research. Stat Med. 1990; 9:469-85.
97. Bioconductor open source software for bioinformatics. http://www.bioconductor.org/ .
98. Liaw A, Wiener M. Classification and regression by randomForest. R News. 2002; 2:18-22.
99. Meyer D, Dimitriadou E, Hornik K, Weingessel A, Leisch F. Misc functions of the Department of Statistics (e1071). 2012. http://cran.r-project.org/package=e1071 .
100. Golden Path track of the University of Santa Cruz Genome Browser. http://hgdownload.cse.ucsc.edu/goldenPath/hg19/gc5Base/.
101. Meyer LR, Zweig AS, Hinrichs AS, Karolchik D, Kuhn RM, Wong M, et al. The UCSC genome browser database: extensions and updates 2013. Nucleic Acids Res. 2013; 41:D64-9.
102. Integrated Haplotype Scores from the University of Chicago. http://hgdp.uchicago.edu/data/iHS/.
103. Genomic Evolutionary Rate Profiling from the Sidow Lab at Stanford University. http://mendel.stanford.edu/SidowLab/downloads/gerp/.
104. Fogarty J, Baker RS, Hudson SE. Case studies in the use of ROC curve analysis for sensor-based estimates in human computer interaction. In: Inkpen K, Van De Panne M, editors. GI 05 Proceedings of Graphics Interface 2005, ACM International Conference Proceeding Series. Canadian Human-Computer Communications Society, Canadian Human-Computer Communications Society: 2005. p. 129-36. http://www.cs.cmu.edu/afs/cs.cmu.edu/misc/mosaic/common/omega/Web/People/jfogarty/publications/gi2005.pdf .
105. Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics (Oxford, England). 2005; 21:3940-1.
106. Open-source software from the Engelhardt Group at Princeton University. http://www.cs.princeton.edu/~bee/software.html .
107. Ernst J, Kellis M. ChromHMM: automating chromatin-state discovery and characterization. Nat. Methods. 2012; 9:215-216.